Updates matching "National"

WASHINGTON, D.C. – Six leading public health and medical organizations today urged the U.S. Food and Drug Administration to take strong and immediate action to address the dramatic rise in teen use of Juul electronic cigarettes, which has been widely reported by media and educators across the United States. The

The American Cancer Society Cancer Action Network (ACS CAN) today released a report examining the most common patient barriers to cancer clinical trial enrollment. Made public at ACS CAN’s annual national policy forum, the report found only about one in four (27%) patients has access to clinical trials where they are being treated. Yet, if asked to enroll in an available trial, more than half of eligible patients typically agree to do so.

WASHINGTON, D.C. – Today the Senate Health, Education, Labor and Pensions Committee (HELP) held a hearing on the Opioid Crisis Response Act of 2018. Included in the proposal are several promising provisions that aim to address addiction while maintaining access to necessary relief for individuals fighting pain from cancer and

A report released today by the Centers for Disease Control and Prevention’s (CDC) Office on Smoking and Health (OSH) provided an updated snapshot of states’ Medicaid coverage for tobacco cessation.

The Centers for Medicare and Medicaid Services (CMS) released a final Medicare rule yesterday that did not include a proposal that would have set hard limits on opioid pain medication at the pharmacy unless an insurer authorized special permission for a larger dose.

Seven public health and medical groups, and several individual pediatricians, filed suit today in federal court in Maryland challenging a U.S. Food and Drug Administration (FDA) decision that allows electronic cigarettes and cigars – including candy-flavored products that appeal to kids – to stay on the market for years without being reviewed by the agency.

The U.S. Senate passed the Childhood Cancer Survivorship, Treatment, Access and Research (STAR) Act. The bipartisan bill would advance pediatric cancer research and increase transparency and expertise for pediatric cancer research at the National Institutes of Health (NIH).